Cas:54934-94-0 1-(cyclohexylmethyl)-4-ethylcyclohexane manufacturer & supplier

We serve Chemical Name:1-(cyclohexylmethyl)-4-ethylcyclohexane CAS:54934-94-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-(cyclohexylmethyl)-4-ethylcyclohexane

Chemical Name:1-(cyclohexylmethyl)-4-ethylcyclohexane
CAS.NO:54934-94-0
Synonyms:Cyclohexane,1-(cyclohexylmethyl)-4-ethyl-,cis;Cyclohexane,1-(cyclohexylmethyl)-4-ethyl-,trans
Molecular Formula:C15H28
Molecular Weight:208.38300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:283.2ºC at 760 mmHg
Density:0.853g/cm3
Index of Refraction:1.464
PSA:
Exact Mass:208.21900
LogP:5.17320

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Cyclohexane,1-(cyclohexylmethyl)-4-ethyl-,cis chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cyclohexane,1-(cyclohexylmethyl)-4-ethyl-,trans physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cyclohexane,1-(cyclohexylmethyl)-4-ethyl-,cis Use and application,Cyclohexane,1-(cyclohexylmethyl)-4-ethyl-,cis technical grade,usp/ep/jp grade.


Related News: Specifically, the EC has cleared Verquvo (vericiguat) to treat patients who are stabilised after a recent decompensation event requiring intravenous therapy. (E)-2-((3,5,5-trihydroxy-4-(hydroxy-24-trioxidaneyl)-24,34,43,54-hexaoxidan-2-enyl)oxy)-13,24,33,43,53,63-hexaoxine manufacturers The site’s workforce currently stands 550-strong. Takeda plans to boost its headcount in Thousand Oaks, though nothing is certain, Hatke said, as quoted by the Business Times. (+-)-N-[1-(5-Benzyl-3-methyl-4-oxo-4,5-dihydro-isoxazolo[5,4-d]pyrimidin-6-yl)-propyl]-4-chloro-N-(2-cyano-ethyl)-benzamide suppliers The jury unanimously ruled in Plexxikon’s favor on all seven questions, including that Novartis has not proved the specification of the patent was full and clear enough to enable a person of “ordinary skill” to make and use the invention. 1H-Purine-2,6-dione, 8-cyclohexyl-3,7-dihydro-3-(2-methylpropyl)- vendor & factory.